PharmaCielo (PCLO.V) has completed initial shipments of its active pharmaceutical ingredients (APIs) to two customers in Brazil following the confirmation of the Company’s compliance with Brazilian Good Manufacturing Practices…
PharmaCielo
PharmaCielo (PCLO.V) is well-positioned to become a preferred cannabis supplier in Mexico in light of the country’s continued efforts towards recreational cannabis legalization. “Mexican cannabis legalization has had several…
PharmaCielo (PCLO.V) entered into an alliance with United States-based cannabinoid extract tester, AssuredTrans, today, according to a press release. The partnership between the two companies provides CBD buyers in…
The United Nations Commission on Narcotic Drugs (CND) removed cannabis from its global narcotic drugs list, also known as the Single Convention on Narcotic Drugs, earlier this week. The…
PharmaCielo (PCLO.V) began to sell and distribute their expanded portfolio of medical cannabis extract products regularly produced at its Rionegro facilities today. The company can now address inquiries customers…
The CPH circus looks to be leaving town after Canadian listed PharmaCielo (PCLO.V) made an all-scrip AUD $122M offer to acquire Creso Pharma (CPH.ASX), which equated to AUD 0.63…